FLORAVANI TM
Natural health product licensed in Canada
- Licence holder
- Himalaya Wellness USA Ltd.
- NPN or DIN-HM
- 80087739
- Status
- Active licence
- Licence date
- 10 August 2018
- Revision date
- 24 November 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cichorium intybus Source : Racine Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 477 mg | 159 mg | Not calculated |
| Embelia ribes Source : Fruit Extract : Matériel brut sec Extraction ratio : 11.11:1 Dry plant equivalent : 61.6605 mg | 5.55 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 55.5 mg | 5.55 mg | Not calculated |
| Mentha arvensis Source : Plante entière Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 13.9 mg | 1.39 mg | Not calculated |
| Citrus limon Source : Fruit Extract : Matériel brut sec Extraction ratio : 6.67:1 Dry plant equivalent : 9.2713 mg | 1.39 mg | Not calculated |
| Carica papaya Source : Fruit Extract : Matériel brut sec Extraction ratio : 6.67:1 Dry plant equivalent : 9.2713 mg | 1.39 mg | Not calculated |
| Piper nigrum Source : Fruit Extract : Matériel brut sec Extraction ratio : 16.67:1 Dry plant equivalent : 19.0038 mg | 1.14 mg | Not calculated |
| Phyllanthus emblica Source : Fruit Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 61.02 mg | 30.51 mg | Not calculated |
| Terminalia chebula Source : Chair (fruit) Extract : Matériel brut sec Extraction ratio : 2.85:1 Dry plant equivalent : 86.982 mg | 30.52 mg | Not calculated |
| Terminalia bellirica Source : Chair (fruit) Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 61.04 mg | 30.52 mg | Not calculated |
| Aconitum bisma Source : Racine Extract : Matériel brut sec Extraction ratio : 4.17:1 Dry plant equivalent : 16.8468 mg | 4.04 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to provide symptomatic relief for management of functional dyspepsia (i.e. epigastric discomfort, nausea, vomiting, belching, fullness in stomach, abdominal distension).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087739
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.